FAQ/Help |
Calendar |
Search |
Today's Posts |
08-16-2010, 12:15 PM | #1 | ||
|
|||
In Remembrance
|
From pipeline email:
Genzyme Acquisition Jeopardizes Future Parkinson's Disease Gene Therapy Trials August 15, 2010 let's hope this is just media hype - it sounds ominous. It has happened before. It sounds alarmist but if you'll notice the financial transactions still control it all. When you see it happen enough times, you get a little "frustrated.". http://www.glgroup.com/News/Genzyme-Acquisition-Jeopardizes-Future-Parkinsons-Disease-Gene-Therapy-Trials-50029.html
__________________
paula "Time is not neutral for those who have pd or for those who will get it." |
||
Reply With Quote |
"Thanks for this!" says: | olsen (08-17-2010) |
Reply |
|
|
Similar Threads | ||||
Thread | Forum | |||
Selling on eBay | Members' Mall | |||
selling a home | The Stumble Inn | |||
NsGene’s proprietary neurotrophic factor, NsG33, will be evaluated by Genzyme for the | ALS |